Oscar Health (OSCR) Cash from Financing Activities (2020 - 2026)

Oscar Health (OSCR) has 7 years of Cash from Financing Activities data on file, last reported at -$3.6 million in Q1 2026.

• Quarterly Cash from Financing Activities fell 173.88% year-over-year to -$3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $390.7 million (up 750.32% YoY) and the FY2025 annual result came in at $399.2 million, up 483.74% from the prior year.
• Cash from Financing Activities slipped to -$3.6 million in Q1 2026, from $8.2 million in the prior quarter.
• In the past five years, Cash from Financing Activities ranged from a high of $364.0 million in Q3 2025 to a low of -$3.6 million in Q1 2026.
• A 5-year average of $45.4 million and a median of $3.8 million in 2024 frame the typical range for Cash from Financing Activities.
• Annual changes were most pronounced in 2024 — Cash from Financing Activities surged 5297.04% — and 2026, when it plunged 173.88%.
• Tracing OSCR's Cash from Financing Activities over 5 years: stood at $527000.0 in 2022, then surged by 102.85% to $1.1 million in 2023, then surged by 257.06% to $3.8 million in 2024, then soared by 114.07% to $8.2 million in 2025, then plunged by 144.06% to -$3.6 million in 2026.
• The last three Cash from Financing Activities figures came in at -$3.6 million (Q1 2026), $8.2 million (Q4 2025), and $364.0 million (Q3 2025), per Business Quant data.